"Use of glycoproteome profiles to detect advanced adenomas and colorectal cancer."

"A novel, highly accurate liquid biopsy-based glycoproteomic predictor of checkpoint inhibitor treatment benefit in advanced non-small cell lung cancer"

"Fucose signatures in peripheral blood glycoproteins are associated with reduced clinical benefit of immune-checkpoint inhibitors in metastatic melanoma"

"Circulating glycopeptide markers differentiate between early- and late-stage epithelial ovarian cancer"

"Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma"

"Clinicians' Perspective on Use of Immune Checkpoint Inhibitors and Related Biomarkers for Solid Tumors"

"Serum glycoproteomic signatures predict overall survival in bone and soft tissue sarcoma patients treated with immune checkpoint inhibitor therapy"

"Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint-inhibitor treatment benefit in metastatic malignant melanoma"

"Liquid-biopsy-derived Glycoproteomic Profiling as a Novel Means for Noninvasive Diagnosis of Ovarian Cancer."

"Glycoproteomics as a powerful liquid biopsy-based screening tool for non-small cell lung cancer."

"Clinicians’ perspective on use of immune checkpoint inhibitors and related biomarkers for solid tumors."

"Identifying potential glycoproteomic biomarkers for diagnosis of colorectal cancer."

"Predicting breast cancer in women using liquid biopsy-derived glycoproteomic markers."

"Peripheral Blood Glycoproteomic Biomarkers As A Powerful New Tool For The Detection Of Nasopharyngeal Carcinoma"

"Glycoproteomics-based Liquid Biopsy Informs Optimal Checkpoint-inhibitor Drug Choice"

"Novel Plasma Glycoprotein Biomarkers Predict Progression-Free Survival In Surgically Resected Clear Cell Renal Cell Carcinoma"

"Differential Peripheral Blood Glycoprotein Profiles In Symptomatic And Asymptomatic COVID-19"

"30 Blood-Based Glycoprotein Signatures In Advanced Non-Small-Cell Lung Carcinoma (NSCLC) Receiving First-Line Immune Checkpoint Blockade"

"Differential Glycoprotein Profiles In Severe And Asymptomatic COVID-19"

"Glycoproteomics As A Powerful Liquid Biopsy-Based Predictor Of Checkpoint-Inhibitor Treatment Response"

"Site-Specific Glycosylation Quantitation Of 50 Serum Glycoproteins Enhanced By Predictive Glycopeptidomics For Improved Disease Biomarker Discovery"

"PB-Net: Automatic Peak Integration By Sequential Deep Learning For Multiple Reaction Monitoring"

"Serum Glycoproteomic-Based Liquid Biopsy For The Detection Of Pancreatic Ductal Adenocarcinoma."